466 Crystallization of Pharmaceutical and Biological Molecules I

Wednesday, November 16, 2016: 8:30 AM - 11:00 AM
Cyril Magnin III (Parc 55 San Francisco)
Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Crystallization and Evaporation

Chair:
Fang Wang
Email: fang.wang@CloverCrystallization.com

Co-chairs:
David am Ende
Email: david.j.amende@nalasengineering.com

Ying Diao
Email: yingdiao@illinois.edu


8:30 AM
Welcoming Remarks

8:35 AM
(466a) Growth and Nucleation Kinetics in Continuous Antisolvent Crystallization Systems
Jennifer Schall, Allan Myerson, Tsaita Lai and Bernhardt L. Trout

8:55 AM
(466b) Evaluation of In Vivo Drug Precipitation or Crystallization Potential through a Novel In Vitro Approach for Method Development and Initial Risk Assessment
Chenchi Wang, Ching Su and Thanga Mariappan

9:15 AM
(466c) Development of New Screening Methodology for the Assessment of the Agglomeration Potential of APIs
Sarah Rothstein, Charles D. Papageorgiou, David am Ende and Eric Martin

9:35 AM
(466d) Parameter Estimation Methods for Salting out Crystallization
Lotfi Derdour and Anjli Patel

9:55 AM
(466e) Electric-Field-Assisted Protein Crystallization in Continuous Flow
Fei Li and Richard Lakerveld

10:15 AM
(466f) Purification of Nitrophenols Using Complex-Assisted Crystallization 
Carlos Pons Siepermann and Allan S. Myerson

10:35 AM
(466g) Rational Pharmaceutical Cocrystallization
Yuriy Abramov

10:55 AM
Concluding Remarks
See more of this Group/Topical: Separations Division
<< Previous Session | Next Session >>